Smart Eye
Smart Eye, the global leader in AI-based Driver Monitoring and Interior Sensing software, announced that it has appointed Detlef Wilke as new Vice President of Automotive Solutions.
GOTHENBURG, SWEDEN / ACCESSWIRE / September 16, 2021 / Smart Eye (STO:SEYE) (OTC PINK:SMTEF) (FRA:SE9): As Vice President of Automotive Solutions, Detlef Wilke will be leading and growing the development of Smart Eye's Driver Monitoring and Interior Sensing solutions. The Automotive Solutions business area was founded in 2012 and has since established Smart Eye as the leading developer of Driver Monitoring System (DMS) software for the automotive industry. With 88 contracts with 13 OEMs, Smart Eye is the clear market leader, delivering its AI-based technology to several of the world's largest car manufacturers.
Detlef Wilke is taking over as Vice President of Automotive Solutions at a key point in the automotive industry's evolution. Recent legislation proposals in the US and China, as well as Euro NCAP's upcoming assessment protocol, all include driver detection technology as a mandatory safety feature, increasing pressure on car manufacturers to implement Driver Monitoring Systems in their upcoming car models.
Smart Eye's Driver Monitoring software is the best equipped solution to deliver on the requirements of Euro NCAP and the new regulations taking shape in the US and China. Since the recent acquisition of Emotion AI pioneer Affectiva, the company is also aptly positioned to lead and accelerate the rapidly growing Interior Sensing market.
"I am very happy to be joining the Smart Eye team at a time when the demand for DMS and Interior Sensing software solutions is rapidly growing", said Detlef Wilke, new Vice President of Automotive Solutions at Smart Eye. "Smart Eye's unparalleled domain expertise combined with their focus on quality and performance positions the company perfectly to lead this market, saving lives and improving our transportation experiences. I look forward to driving new growth opportunities, adding my experience and passion to the highly skilled and committed team."
"I am excited to welcome Detlef Wilke to Smart Eye," said Martin Krantz, CEO and Founder of Smart Eye. "His deep technical expertise in building Interior Sensing systems and developing DMS solutions will be incredibly valuable for Smart Eye as we expand our automotive footprint."
Detlef Wilke is leaving his previous position at Aptiv (formerly Delphi) after 23 years with the company. His focus was on Driver Monitoring and Interior Sensing after seven years in a number of parallel roles, ranging from Technical Management, Project Leadership, and Solution and Quote Strategies Leadership. In his prior role he successfully built up and shaped business and technology in the areas of Driver- and Interior Monitoring. Previously, he was active in leading roles for OEM- and Aftermarket Connectivity Telematics hardware and software. As Chairman of the CLEPA Mirror Group for Euro NCAP Occupant Status Monitoring, Detlef was deeply involved in the NCAP and legislative strategies.
Contact:
Gabi Zijderveld, CMO Smart Eye AB
Phone: +1 781.996.3037
Email: Gabriele.Zijderveld@smarteye.ai
Hailey Melamut
March Communications
Phone: +1 617.960.9856
Email: hailey@marchcomms.com
About Smart Eye
Smart Eye is leading the way towards safe and sustainable transportation. Every year, 1.2 million people lose their lives in traffic-related accidents around the world, another 50 million are injured. Our firm belief is that science and technology can help turn this around.
For over 20 years Smart Eye has developed artificial intelligence (AI) in the form of eye tracking technology that understands, supports and predicts a person's intentions and actions. By carefully studying eye, facial and head movement, our technology can draw conclusions about a person's awareness and mental state. Our eye tracking technology is used in the next generation of cars, commercial vehicles and providing new insights for research within aerospace, aviation, neuroscience and more.
Smart Eye's solutions are used around the world by more than 800 partners and customers, including the US Air Force, NASA, BMW, Audi, Boeing, Volvo, GM, and Harvard University.
Visit www.smarteye.ai for more information.
Visit our investor web for more financial information: http://www.corp.smarteye.se/en/
Smart Eye is listed on Nasdaq First North Growth Market. Erik Penser is Certified Adviser and can be reached at +46-8-463 8000 or certifiedadviser@penser.se.
Image Attachments
SOURCE: Smart Eye
View source version on accesswire.com:
https://www.accesswire.com/664353/Smart-Eye-Announces-Detlef-Wilke-as-New-VP-of-Automotive-Solutions
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom